Clinical Trial Update: Treat_CCM: Propranolol in Familial Cerebral Cavernous Malformation [Phase 2]

View source ↗

Summary

Phase 2 trial update for Propranolol in cerebral cavernous malformation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cerebral Cavernous Malformation

Drugs mentioned

• Propranolol (propranolol)

Snippet

Sponsor: Mario Negri Institute for Pharmacological Research | Conditions: Cerebral Cavernous Malformation | Phase 2 | Status: COMPLETED